Dr. Hurria on Treatment Options for the Geriatric Population with Breast Cancer

Arti Hurria, MD
Published Online: Monday, Jul 17, 2017



Arti Hurria, MD, director, Cancer and Aging Research Program, co-leader, Cancer Control and Population Sciences Program, professor, Department of Medical Oncology and Therapeutics Research and Department of Population Sciences, discusses treatment for the geriatric patient population with breast cancer.

The aging process is heterogeneous, making it important to individualize medicine for the older population, explains Hurria.

By incorporating the principles of geriatrics into the oncologic care, the physician can receive a better understanding of the patient’s functional age in comparison to their chronological age, states Hurria.
 


Arti Hurria, MD, director, Cancer and Aging Research Program, co-leader, Cancer Control and Population Sciences Program, professor, Department of Medical Oncology and Therapeutics Research and Department of Population Sciences, discusses treatment for the geriatric patient population with breast cancer.

The aging process is heterogeneous, making it important to individualize medicine for the older population, explains Hurria.

By incorporating the principles of geriatrics into the oncologic care, the physician can receive a better understanding of the patient’s functional age in comparison to their chronological age, states Hurria.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections: 15th Annual International Congress on the Future of Breast Cancer®Oct 06, 20172.0
Medical Crossfire®: Leveraging New Evidence in the Context of Evolving Early-Stage Treatment Standards in HER2-Positive Breast CancerJan 30, 20181.5
Publication Bottom Border
Border Publication